{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:44:46Z","timestamp":1788633886629,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NIAAA","award":["R01AA017626"],"award-info":[{"award-number":["R01AA017626"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75219-1","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:02:09Z","timestamp":1729256529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chromosome 8q24 amplification associated with human hepatocellular carcinoma predicts MYC\/ZEB1\/MIZ1 transcriptional regulation"],"prefix":"10.1038","volume":"14","author":[{"given":"Joeffrey J.","family":"Chahine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniya S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeyye","family":"Culfaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar V.","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Tuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"75219_CR1","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.xcrm.2023.101170","volume":"4","author":"AM Roy","year":"2023","unstructured":"Roy, A. M. & Iyer, R. The extracellular matrix in hepatocellular carcinoma: mechanisms and therapeutic vulnerability. Cell. Rep. Med. 4, 101170 (2023).","journal-title":"Cell. Rep. Med."},{"key":"75219_CR2","doi-asserted-by":"crossref","unstructured":"Brabletz, S., Schuhwerk, H., Brabletz, T. & Stemmler, M. P. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 40, 896 (2021).","DOI":"10.15252\/embj.2021108647"},{"key":"75219_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.devcel.2019.04.026","volume":"49","author":"R Derynck","year":"2019","unstructured":"Derynck, R. & Weinberg, R. A. EMT and cancer: more than meets the eye. Dev. Cell 49, 313\u2013316 (2019).","journal-title":"Dev. Cell"},{"key":"75219_CR4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ncb3611","volume":"19","author":"J Varga","year":"2017","unstructured":"Varga, J. & Greten, F. R. Cell plasticity in epithelial homeostasis and tumorigenesis. Nat. Cell Biol. 19, 1133\u20131141 (2017).","journal-title":"Nat. Cell Biol."},{"key":"75219_CR5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119, 1429\u20131437 (2009).","journal-title":"J. Clin. Invest."},{"key":"75219_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2350-12-156","volume":"12","author":"AG Brisbin","year":"2011","unstructured":"Brisbin, A. G. et al. Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development. BMC Med. Genet. 12, 156 (2011).","journal-title":"BMC Med. Genet."},{"key":"75219_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fgene.2012.00069","volume":"3","author":"K Huppi","year":"2012","unstructured":"Huppi, K., Pitt, J. J., Wahlberg, B. M. & Caplen, N. J. The 8q24 gene desert: an oasis of non-coding transcriptional activity. Front. Genet. 3, 69 (2012).","journal-title":"Front. Genet."},{"key":"75219_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/hep.22033","volume":"47","author":"C Schlaeger","year":"2008","unstructured":"Schlaeger, C. et al. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47, 511\u2013520 (2008).","journal-title":"Hepatology"},{"key":"75219_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/ijo.2012.1474","volume":"41","author":"DB Zimonjic","year":"2012","unstructured":"Zimonjic, D. B. & Popescu, N. C. NC. Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review). Int. J. Oncol. 41, 393\u2013406 (2012).","journal-title":"Int. J. Oncol."},{"key":"75219_CR10","doi-asserted-by":"publisher","first-page":"22622","DOI":"10.1038\/s41598-022-27173-z","volume":"12","author":"J Friemel","year":"2022","unstructured":"Friemel, J. et al. Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions. Sci. Rep. 12, 22622 (2022).","journal-title":"Sci. Rep."},{"key":"75219_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrm1703","volume":"6","author":"S Adhikary","year":"2005","unstructured":"Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by myc proteins. Nat. Rev. Mol. Cell. Biol. 6, 635\u2013645 (2005).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"75219_CR12","doi-asserted-by":"crossref","unstructured":"Kalkat, M. et al. MYC deregulation in primary human cancers. Genes (Basel) 2017, 8 (2017).","DOI":"10.3390\/genes8060151"},{"key":"75219_CR13","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1172\/JCI76725","volume":"126","author":"JE Larsen","year":"2016","unstructured":"Larsen, J. E. et al. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J. Clin. Invest. 126, 3219\u20133235 (2016).","journal-title":"J. Clin. Invest."},{"key":"75219_CR14","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.3390\/ijms21207710","volume":"21","author":"EM Me\u0161kyt\u0117","year":"2020","unstructured":"Me\u0161kyt\u0117, E. M., Keskas, S. & Ciribilli, Y. MYC as a multifaceted regulator of tumor microenvironment leading to metastasis. Int. J. Mol. Sci. 21, 7710 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"75219_CR15","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1038\/sj.onc.1210508","volume":"26","author":"K Aigner","year":"2007","unstructured":"Aigner, K. et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26, 6979\u20136988 (2007).","journal-title":"Oncogene"},{"key":"75219_CR16","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","volume":"69","author":"T Arumugam","year":"2009","unstructured":"Arumugam, T. et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 69, 5820\u20135828 (2009).","journal-title":"Cancer Res."},{"key":"75219_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.tcb.2014.10.006","volume":"25","author":"E Wolf","year":"2014","unstructured":"Wolf, E., Lin, C. Y., Eilers, M. & Levens, D. L. Taming of the beast: shaping myc-dependent amplification. Trends Cell. Biol. 25, 241\u2013248 (2014).","journal-title":"Trends Cell. Biol."},{"key":"75219_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12885-015-1111-6","volume":"15","author":"C Dalmasso","year":"2015","unstructured":"Dalmasso, C. et al. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma. BMC Cancer 15, 126 (2015).","journal-title":"BMC Cancer"},{"key":"75219_CR19","doi-asserted-by":"crossref","unstructured":"Koo, S. H. et al. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet. Cytogenet. 130, 569 (2001).","DOI":"10.1016\/S0165-4608(01)00460-5"},{"key":"75219_CR20","doi-asserted-by":"crossref","unstructured":"Ziegelbauer, J., Wei, J. & Tjian, R. Myc-interacting protein 1 target gene profile: A link to microtubules, extracellular signal-regulated kinase, and cell growthvol. Proc. Natl. Acad. Sci. U. S. A. 101, 4718\u20134718 (2004).","DOI":"10.1073\/pnas.0307562100"},{"key":"75219_CR21","doi-asserted-by":"publisher","first-page":"16736","DOI":"10.1073\/pnas.1412152111","volume":"111","author":"T Mund","year":"2014","unstructured":"Mund, T., Lewis, M. J., Maslen, S. & Pelham, H. R. Peptide and small molecule inhibitors of HECT-type ubiquitin ligases. Proc. Natl. Acad. Sci. U. S. A. 111, 16736\u201316741 (2014).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"75219_CR22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.15252\/emmm.201403927","volume":"6","author":"S Peter","year":"2014","unstructured":"Peter, S. et al. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol. Med. 6, 1525\u20131541 (2014).","journal-title":"EMBO Mol. Med."},{"key":"75219_CR23","doi-asserted-by":"crossref","unstructured":"Liu, K., Chen, J. & McCaughan, G. W. Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases. Hepatoma Res. 6, 852 (2020).","DOI":"10.20517\/2394-5079.2019.39"},{"key":"75219_CR24","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1093\/emboj\/16.18.5672","volume":"16","author":"K Peukert","year":"1997","unstructured":"Peukert, K. et al. An alternative pathway for gene regulation by Myc. EMBO J. 16, 5672\u20135686 (1997).","journal-title":"EMBO J."},{"key":"75219_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi, P. A. & DePinho, R. A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 6, 674\u2013687 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"75219_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","volume":"70","author":"N Ganne-Carrie","year":"2019","unstructured":"Ganne-Carrie, N. & Nahon, P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J. Hepatol. 70, 284\u2013293 (2019).","journal-title":"J. Hepatol."},{"key":"75219_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13238-014-0065-9","volume":"5","author":"M Liu","year":"2014","unstructured":"Liu, M., Jiang, L. & Guan, X. Y. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell. 5, 673\u2013691 (2014).","journal-title":"Protein Cell."},{"key":"75219_CR28","doi-asserted-by":"crossref","unstructured":"Ramadori, P., Cubero, F. J., Liedtke, C., Trautwein, C. & Nevzorova, Y. A. Alcohol and Hepatocellular Carcinoma: adding fuel to the Flame. Cancers 9, 236 (2017).","DOI":"10.3390\/cancers9100130"},{"key":"75219_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jceh.2019.01.004","volume":"9","author":"A Jindal","year":"2019","unstructured":"Jindal, A., Thadi, A. & Shailubhai, K. Hepatocellular carcinoma: etiology and current and future drugs. J. Clin. Experimental Hepatol. 9, 221\u2013232 (2019).","journal-title":"J. Clin. Experimental Hepatol."},{"key":"75219_CR30","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.cellsig.2013.08.028","volume":"25","author":"KJ Wu","year":"2013","unstructured":"Wu, K. J. et al. Silibinin inhibits beta-catenin\/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cell. Signal. 25, 2625\u20132633 (2013).","journal-title":"Cell. Signal."},{"key":"75219_CR31","doi-asserted-by":"publisher","first-page":"831","DOI":"10.15252\/emmm.201404396","volume":"7","author":"S Meidhof","year":"2015","unstructured":"Meidhof, S. et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol. Med. 7, 831\u2013847 (2015).","journal-title":"EMBO Mol. Med."},{"key":"75219_CR32","unstructured":"Sobin, L., Gospodarowicz, M. & Wittekind, C. TNM Classification of Malignant Tumors (Wiley-Blackwell, 2009)."},{"key":"75219_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1083\/jcb.123.6.1761","volume":"123","author":"G Ihrke","year":"1993","unstructured":"Ihrke, G. et al. WIF-B cells: an in vitro model for studies of hepatocyte polarity. J. Cell. Biol. 123, 1761\u20131775 (1993).","journal-title":"J. Cell. Biol."},{"key":"75219_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680\u2013685 (1970).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75219-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:23:17Z","timestamp":1729257797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75219-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75219"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75219-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"23 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24488"}}